Approximately 80% of low-grade glioma (LGGs) harbor mutant isocitrate dehydrogenase 1/2 (IDH1/2) driver mutations leading to accumulation of the oncometabolite 2-hydroxyglutarate (2-HG). Thus, inhibition of mutant IDH is considered a potential therapeutic target. Several mutant IDH inhibitors are currently in clinical trials, including AG-881 and BAY-1436032. However, to date, early detection of response remains a challenge. In this study we used high resolution 1H magnetic resonance spectroscopy (1H-MRS) to identify early noninvasive MR-detectable metabolic biomarkers of response to mutant IDH inhibition. In vivo 1H-MRS was performed on mice orthotopically-implanted with either genetically engineered (U87IDHmut) or patient-derived (BT257 a...
BackgroundThere is considerable interest in defining the metabolic abnormalities of IDH mutant tumor...
Malignant gliomas are the most common primary brain tumours in adults. Due to their diffuse nature a...
AbstractMutations in the isocitrate dehydrogenase (IDH) genes are frequently found in gliomas and in...
Approximately 80% of low-grade glioma (LGGs) harbor mutant isocitrate dehydrogenase 1/2 (IDH1/2) dri...
Mutations in isocitrate dehydrogenase 1 (IDH1mut) are reported in 70-90% of low-grade gliomas and se...
Inhibitors of the mutant isocitrate dehydrogenase 1 (IDH1) entered recently in clinical trials for g...
Although lower grade gliomas are driven by mutations in the isocitrate dehydrogenase 1 (IDH1) gene a...
BackgroundInhibition of the isocitrate dehydrogenase (IDH)-mutant enzyme is a novel therapeutic targ...
Purpose: Measurements of objective response rates are critical to evaluate new glioma therapies. The...
The oncogenes that are expressed in gliomas reprogram particular pathways of glucose, amino acids, a...
Simple Summary Approximately 75-80% of according to the classification of world health organization ...
The oncogenes that are expressed in gliomas reprogram particular pathways of glucose, amino acids, a...
Mutations in isocitrate dehydrogenase (IDH) 1 have been reported in over 70% of low-grade gliomas an...
The isocitrate dehydrogenase (IDH) mutation status is an indispensable prerequisite for diagnosis of...
70-90% of low-grade gliomas and secondary glioblastomas are characterized by mutations in isocitrate...
BackgroundThere is considerable interest in defining the metabolic abnormalities of IDH mutant tumor...
Malignant gliomas are the most common primary brain tumours in adults. Due to their diffuse nature a...
AbstractMutations in the isocitrate dehydrogenase (IDH) genes are frequently found in gliomas and in...
Approximately 80% of low-grade glioma (LGGs) harbor mutant isocitrate dehydrogenase 1/2 (IDH1/2) dri...
Mutations in isocitrate dehydrogenase 1 (IDH1mut) are reported in 70-90% of low-grade gliomas and se...
Inhibitors of the mutant isocitrate dehydrogenase 1 (IDH1) entered recently in clinical trials for g...
Although lower grade gliomas are driven by mutations in the isocitrate dehydrogenase 1 (IDH1) gene a...
BackgroundInhibition of the isocitrate dehydrogenase (IDH)-mutant enzyme is a novel therapeutic targ...
Purpose: Measurements of objective response rates are critical to evaluate new glioma therapies. The...
The oncogenes that are expressed in gliomas reprogram particular pathways of glucose, amino acids, a...
Simple Summary Approximately 75-80% of according to the classification of world health organization ...
The oncogenes that are expressed in gliomas reprogram particular pathways of glucose, amino acids, a...
Mutations in isocitrate dehydrogenase (IDH) 1 have been reported in over 70% of low-grade gliomas an...
The isocitrate dehydrogenase (IDH) mutation status is an indispensable prerequisite for diagnosis of...
70-90% of low-grade gliomas and secondary glioblastomas are characterized by mutations in isocitrate...
BackgroundThere is considerable interest in defining the metabolic abnormalities of IDH mutant tumor...
Malignant gliomas are the most common primary brain tumours in adults. Due to their diffuse nature a...
AbstractMutations in the isocitrate dehydrogenase (IDH) genes are frequently found in gliomas and in...